Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study

BACKGROUND: Several studies have suggested a survival benefit of neoadjuvant therapy (NAT) for pancreatic ductal adenocarcinoma (PDAC) in the pancreatic head. Data concerning NAT for PDAC located in pancreatic body or tail are lacking. METHODS: Post hoc analysis of an international multicenter retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lof, Sanne, Korrel, Maarten, van Hilst, Jony, Alseidi, Adnan, Balzano, Gianpaolo, Boggi, Ugo, Butturini, Giovanni, Casadei, Riccardo, Dokmak, Safi, Edwin, Bjørn, Falconi, Massimo, Keck, Tobias, Malleo, Giuseppe, de Pastena, Matteo, Tomazic, Ales, Wilmink, Hanneke, Zerbi, Alessandro, Besselink, Marc G., Abu Hilal, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Pancreatic Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210228/
https://www.ncbi.nlm.nih.gov/pubmed/31848815
http://dx.doi.org/10.1245/s10434-019-08137-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210228/
https://www.ncbi.nlm.nih.gov/pubmed/31848815
http://dx.doi.org/10.1245/s10434-019-08137-6

Ejemplares similares